However , when the newly diagnosed group was compared with the no diabetes group , no significant difference was observed in cardiovascular ( HR = 0.33 ; 95 % CI = 0.11-1 .05 ) or all-cause mortality ( HR = 0.76 ; 95 % CI = 0.47-1 .23 ) either during the ANBP2 trial or including post-trial follow-up ( cardiovascular : HR = 0.82 ; 95 % CI = 0.58-1 .17 ; all-cause mortality : HR = 1.04 ; 95 % CI = 0.85-1 .27 ) .